Vivimed Labs is currently trading at Rs. 22.80, up by 0.05 points or 0.22% from its previous closing of Rs. 22.75 on the BSE.
The scrip opened at Rs. 22.30 and has touched a high and low of Rs. 23.65 and Rs. 21.35 respectively. So far 58780 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 91.80 on 29-Jan-2018 and a 52 week low of Rs. 21.25 on 22-Jan-2019.
Last one week high and low of the scrip stood at Rs. 26.90 and Rs. 21.35 respectively. The current market cap of the company is Rs. 188.57 crore.
The promoters holding in the company stood at 36.58%, while Institutions and Non-Institutions held 4.72% and 58.71% respectively.
Vivimed Labs’ (VLL) board has approved to sell its stake in 50:50 JV with Strides. This step is aimed towards augmenting management focus on the growing FDF portfolio across India, RoW and CIS markets.
It is also going to improve financial flexibility for the domestic finished dosage business and reduction of long term leverage in the Indian operations. Consequently, VLL will sell balance 50% stake in Vivimed Life Sciences, India to Strides Pharma Science and the balance 50% stake in Strides Vivimed, Singapore to Strides Pharma Global, Singapore.
Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: